EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cross‐reactivity among and between macrolides, lincosamides, and streptogramins: Study on the French pharmacovigilance database

Quentin Le Baron, Delphine Bourneau-Martin iD, Marina Babin, Aurore Gouraud, Marie Tauber, Audrey Fresse iD, Bénédicte Lebrun-Vignes, Juliette Delaunay, Martine Morisset, Marie Briet iD

Fundamental & Clinical Pharmacology · 2024

DOI: 10.1111/fcp.13005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2024. Verfasst von Quentin Le Baron und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology-Toxicology and Pharmacovigilance, University Hospital of Angers, Angers, France. Hauptthemen laut MEDLINE: Cross Reactions, Pharmacovigilance, Lincosamides, Macrolides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypersensitivity reactions (HSR) are reported for the macrolides, lincosamides, and streptogramins (MLS) antibiotic family. Data about cross‐reactivity among and between MLS remain scarce or controversial.

Objectives

The aim of this study was to provide an overview of hypersensitivity cross‐reactions among MLSs based on data extracted from the French National Pharmacovigilance Database (FPVD).

Methods

Cases of HSR to MLSs reported between January 1985 and December 2019 were extracted from the FPVD using standardized MedDRA queries (SMQ). Cases including an allergological test involving multiple MLSs and giving at least one positive result were included.

Results

Of the 8394 cases reviewed, 149 were included. HSR mainly involved pristinamycin ( n = 83; 53.2%) and spiramycin ( n = 31; 19.9%). HSR to MLS was immediate in 54 cases and delayed in 94 cases. Skin tests represented the majority of the allergological tests performed ( n = 728; 84.7%), followed by reintroduction tests ( n = 79; 9.2%). Eighty‐six cross‐reactivities among MLS were identified in 62 cases (41.6%). All the 25 explorations performed for streptogramins showed cross‐reactivities, but only 30/253 among macrolides (11.9%). Cross‐reactivities between the three MLS were observed in 31/322 (9.6%) of the allergological explorations.

Conclusion

This study highlights the possibility of cross‐reactivity among and between MLSs. Dermatologists and allergologists managing patients with HSR to MLSs should be aware of a risk of cross‐reactivity among the macrolides and between the different classes of MLS and to perform MLSs allergological testing before recommending an alternative antibiotic, especially in severe drug hypersensitivity from the MLS family.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross ReactionsPharmacovigilanceLincosamidesMacrolidesAnti-Bacterial AgentsDrug HypersensitivityDatabases, FactualStreptograminsHumansFranceMaleFemaleAdultMiddle AgedAgedAdolescentYoung AdultChildSkin TestsAdverse Drug Reaction Reporting SystemsChild, Preschool

Stichwörter der Autor:innen

cross‐reactivitydrug hypersensitivitygroup a/group b streptograminlincosamidesmacrolidespharmacovigilance

Substanzen

LincosamidesMacrolidesAnti-Bacterial AgentsStreptogramins

Autor:innen und Institutionen

  • Department of Pharmacology-Toxicology and Pharmacovigilance, University Hospital of Angers, Angers, France.
  • CRPV, CHU Lyon, Lyon, France.
  • Department of Allergology and Clinical Immunology, Inserm 1111 CIRI, CHU Lyon, Lyon, France.
  • French Investigators for Skin Adverse Reactions to Drugs (FISARD) group from the French Society of Dermatology, Paris, France.
  • CRPV, CHRU Nancy, Nancy, France.
  • CRPV Paris Pitié-St Antoine, APHP, Sorbonne Université, Paris, France.

ORCID-Profile: Delphine Bourneau-Martin, Audrey Fresse, Marie Briet

Zitieren

APA

Le Baron, Q., Bourneau-Martin, D., Babin, M., Gouraud, A., Tauber, M., Fresse, A., Lebrun-Vignes, B., Delaunay, J., Morisset, M., & Briet, M. (2024). Cross‐reactivity among and between macrolides, lincosamides, and streptogramins: Study on the French pharmacovigilance database. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.13005

Vancouver

Le Baron Q, Bourneau-Martin D, Babin M, Gouraud A, Tauber M, Fresse A, et al. Cross‐reactivity among and between macrolides, lincosamides, and streptogramins: Study on the French pharmacovigilance database. Fundamental & Clinical Pharmacology. 2024. doi:10.1111/fcp.13005

BibTeX
@article{LeBaron2024,
  author = {Le Baron, Quentin and Bourneau-Martin, Delphine and Babin, Marina and Gouraud, Aurore and Tauber, Marie and Fresse, Audrey and Lebrun-Vignes, Bénédicte and Delaunay, Juliette and Morisset, Martine and Briet, Marie},
  title = {Cross‐reactivity among and between macrolides, lincosamides, and streptogramins: Study on the French pharmacovigilance database},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/fcp.13005}
}
Kostenlos starten →